Mindray Medical International Ltd (MR) 27.94 $MR
Mindray Announces Completion of Going Private Transaction
PR Newswire - Thu Mar 03, 3:01PM CST
Mindray Medical International Limited ("Mindray" or the "Company", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the completion of its merger (the "merger"
with Solid Union Limited ("Merger Sub" , a wholly-owned subsidiary of Excelsior Union Limited ("Parent" , pursuant to the previously announced agreement and plan of merger (the "Merger Agreement" dated as of November 4, 2015 and amended on December 20, 2015, among the Company, Parent and Merger Sub. As a result of the merger, the Company has ceased to be a publicly traded company and became a wholly owned subsidiary of Parent.
MR: 27.94 (+0.07)
11.7% Return Seen to Date on SmarTrend Mindray Medical International Call (MR)
Comtex SmarTrend(R) - Wed Mar 02, 12:02PM CST
SmarTrend identified an Uptrend for Mindray Medical International (NYSE:MR) on November 3rd, 2015 at $24.91. In approximately 4 months, Mindray Medical International has returned 11.70% as of today's recent price of $27.83.
MR: 27.94 (+0.07)
Profitable Ideas in Untold Names -- TransEnterix, Endologix, Mindray Medical Intl., and Hill-Rom Holdings
ACCESSWIRE - Tue Feb 09, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / February 09, 2016 / At ValuableInvestment.com we are aware that volume and moving average numbers impress. So, these are the top trades, TransEnterix Inc. (NYSE MKT: TRXC), Endologix Inc. (NASDAQ: ELGX), Mindray Medical International Ltd (NYSE:MR), and Hill-Rom Holdings Inc. (NYSE: HRC), for making money when big names are down. Find out which stocks could produce triple digit returns this month by clicking here:
TRXC: 1.45 (unch), MR: 27.94 (+0.07), ELGX: 12.88 (+0.20), HRC: 49.35 (-0.75)
BRIC Haematology Market Outlook to 2021
M2 - Tue Jan 19, 10:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lfvn3k/bric_haematology) has announced the addition of the "BRIC Haematology Market Outlook to 2021" report to their offering. "BRIC Haematology Market Outlook to 2021", provides key market data on the BRIC Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the BRIC Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Haematology Market, BRIC 4 Haematology Market, Brazil 5 Haematology Market, Russia 6 Haematology Market, India 7 Haematology Market, China 8 Overview of Key Companies in BRIC Haematology Market 9 Haematology Market Pipeline Products 10 Appendix Companies featured - Siemens Healthcare - Sysmex Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Horiba, Ltd. - Transasia Bio-Medicals Ltd. - Mindray Medical International Limited - Trivitron Healthcare Pvt Ltd. - Bio-Rad Laboratories, Inc. - bioMerieux S.A. For more information visit http://www.researchandmarkets.com/research/lf...aematology
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
Global Ultrasound Market Report 2016-2021 - Market is Dominated by GE, Siemens & Philips
M2 - Tue Jan 19, 9:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/dzgr8z/global_ultrasound) has announced the addition of the "Global Ultrasound Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global ultrasound market is expected to grow at a CAGR of 5% for the forecasted period of 2015-2021 The market is dominated by some of the major healthcare companies which includes GE healthcare, Siemens healthcare and Philips healthcare. Market growth is driven by various factors which includes increase in the number of cancer patients which is creating huge demand for ultrasound system market. Rise in the prevalence of CVD and other life style oriented diseases is also driving the ultrasound system market. Ultrasound is widely used to monitor the growth of baby during pregnancy, hence a constant rise in birth rates and awareness amongst the masses creates huge scope for ultrasound system market. Innovations such as advent of 3D and 4D imaging is creating opportunities for the market player. However, the market is restrained by few factors such as reimbursement policies in emerging nations. The high price and unavailability of reimbursements keeps a large group of patients from using ultrasound services. Market is segmented on the basis of technology, applications and products. Ultrasound system market by technology includes diagnostics ultrasound market and therapeutic ultrasound market. The ultrasound system market which is also segmented on the basis of product includes segmentation on the basis of displays, on the basis of portability. Ultrasound system market is also segmented on the basis of applications which include radiology imaging applications gynaecological, cardio logical, and urological and others. Europe accounted for highest market share driven by an aging population and high awareness related to life threatening diseases. North America has the second highest market share followed by Asia Pacific and Rest of the world. Asia Pacific market has the highest market growth. Asia Pacific market is expected to grow at a CAGR of 6%. The market includes major companies such as Analogic Corporation, Esaote S.P.A, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Mindray Medical International Ltd., and Philips Healthcare, Samsung, Medison Co. Ltd., Siemens Healthcare and other. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Analogic Corporation - Esaote S.P.A - Fujifilm Holdings Corporation - GE Healthcare - Hitachi Medical Corporation - Mindray Medical International Ltd. - Philips Healthcare - Samsung Medison Co. Ltd. - Siemens Healthcare - Medtronic Inc - Toshiba Medical Systems Corporation - Roche Diagnostics Ltd. - Philips corporation - Stryker corporation - Smith and nephew inc - Johnson & Johnson - Sony - Zimmer holdings - St. Jude medical Inc - Thermo fisher scientific - Abiant Inc - EKF diagnostics holdings inc - Myriad RBM inc - Oligomerix inc - Opko health inc - Osta biotechnologies inc - Psynova neurotech ltd - Ridge diagnostics - Satori pharmaceutical inc For more information visit http://www.researchandmarkets.com/research/dz...ultrasound
JNJ: 116.79 (-0.22), MDT: 85.70 (unch), ALOG: 83.75 (-0.50), MR: 27.94 (+0.07), SYK: 114.44 (-0.12)
Global MRI Systems Market Report 2015-2021 - Global increase in neurological diseases is expected to drive MRI systems market
M2 - Tue Jan 19, 8:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/wcsjfb/global_mri) has announced the addition of the "Global MRI Systems Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global MRI systems market is expected to grow at a CAGR of 5.2% for the forecasted period of 2015 to 2021 MRI systems market is driven by various factors which include global increase in neurological diseases, global rise in cancer, CVD and other life style oriented diseases, global rise in adoption of diagnostics system. Research and development, innovation and technological advancement enables the global MRI systems market to grow fast. Global rise in healthcare expenditure is also favourable for global MRI systems market. However, the market is restrained by reimbursement policies in various regions especially emerging markets such as India and China. There is a very high cost involved in setting up MRI systems in hospitals and clinics. The hospitals and clinics have to make infrastructural changes to accommodate a new MRI machine. Some MRI machines may cost over $800,000 to $1 million. Market also faces challenges such as creating awareness in emerging economies and stringent government policies and regulations. Market segmentation is on the basis of application which includes brain and neurological MRI market, spine and musculoskeletal MRI market, vascular MRI market, pelvic and abdominal MRI market, breast MRI market and cardiac MRI market. MRI market is also segmented on the basis of architecture which includes closed MRI systems market and open MRI systems market. Field strength is also taken as a basis of segmentation. The sub segments include low to mid field MRI systems, high field MRI systems, very high field MRI systems and ultra-high field MRI systems. North American market has the highest market share amongst geographies. It is followed by Asia Pacific, Europe and Rest of the world. Asia Pacific market is expected to record highest CAGR amongst all regions. Market consists of major players such as Aurora imaging technology Inc, Esoate SPA, Fona corporation, IMRIS, Inc, Neusoft medical systems co. ltd, Philips healthcare, Esaote S.P.A, GE Healthcare, Hitachi Medical Corporation and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographic analysis 8. Company Profiles - Aurora imaging technology Inc - Esoate SPA - Fona corporation - IMRIS, Inc - Neusoft medical systems s co. ltd - Philips healthcare - Esaote S.P.A - GE Healthcare - Hitachi Medical Corporation - Mindray Medical International Ltd. - Samsung Medison Co. Ltd. - Siemens Healthcare - Medtronic Inc - Toshiba Medical Systems s Corporation - Roche Diagnostics Ltd. - Philips corporation - Stryker corporation - Smith and nephew Inc - Johnson & Johnson - Sony - Zimmer holdings - St. Jude medical Inc - Thermo fisher scientific - Abiant Inc - EKF diagnostics holdings Inc - Myriad RBM Inc - Oligomerix Inc - Opko health Inc - Osta biotechnologies Inc - Psynova neurotech ltd - Ridge diagnostics For more information visit http://www.researchandmarkets.com/research/wcsjfb/global_mri
JNJ: 116.79 (-0.22), MDT: 85.70 (unch), MR: 27.94 (+0.07), SYK: 114.44 (-0.12)
Mindray Announces Extraordinary General Meeting of Shareholders
PR Newswire - Tue Jan 19, 7:11AM CST
Mindray Medical International Limited ("Mindray" or the "Company", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has called an extraordinary general meeting of shareholders (the "EGM" , to be held on February 26, 2016 at 11:00 a.m. (Hong Kong time), at the Company's Hong Kong office at FLAT/RM 15-16 BLK 1 11/F, Grand Century, 193 Prince Edward West Road, Mongkok KL, Hong Kong. The meeting is being held to consider and vote on, among other matters, the proposal to authorize and approve the previously announced agreement and plan of merger (the "Merger Agreement" dated as of November 4, 2015 as amended on December 20, 2015, among the Company, Excelsior Union Limited ("Parent" and Solid Union Limited, a wholly owned subsidiary of Parent ("Merger Sub" , the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, substantially in the form attached as Annex A to the Merger Agreement (the "Plan of Merger" , and the transactions contemplated thereby, including the Merger (as defined below).
MR: 27.94 (+0.07)
EU5 Clinical Chemistry Market Outlook to 2021
M2 - Fri Jan 15, 7:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/ns6xbw/eu5_clinical) has announced the addition of the "EU5 Clinical Chemistry Market Outlook to 2021" report to their offering. "EU5 Clinical Chemistry Market Outlook to 2021", provides key market data on the EU5 Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the EU5 Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, EU5 4 Clinical Chemistry Market, France 5 Clinical Chemistry Market, Germany 6 Clinical Chemistry Market, Italy 7 Clinical Chemistry Market, Spain 8 Clinical Chemistry Market, United Kingdom 9 Overview of Key Companies in EU5 Clinical Chemistry Market 10 Clinical Chemistry Market Pipeline Products 11 Recent Developments 12 Appendix Companies Mentioned - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Danaher Corporation - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation - ELITech Group - Mindray Medical International Limited For more information visit http://www.researchandmarkets.com/research/ns...5_clinical
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
Global Companion Animal Diagnostics Market Worth USD 1.55 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: ABAXIS, Elanco & Neogen Corporation
M2 - Thu Jan 14, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/qjqfhw/global_companion) has announced the addition of the "Global Companion Animal Diagnostics Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Companion Animal Diagnostics Market is poised to grow at a CAGR of around 8.9% in the next 5 years to reach approximately $1.55 billion by 2020. This industry report analyzes the global markets for Companion Animal Diagnostics across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The market data is gathered from extensive primary research and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures. The Companion Animal Diagnostics Market report provides 161 data tables, includes charts and graphs for visual analysis. Key Topics Covered: - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Companies Mentioned: - ABAXIS, Inc. - Boehringer Ingelheim - Elanco - HESKA Corporation - IDEXX Laboratories, Inc. - IDVET - Merck - Mindray Medical International Ltd. - Neogen Corporation - Thermo Fisher Scientific Inc - VCA Antech, Inc. - Virbac SA - Zoetis, Inc. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Companion Animal Diagnostics Market, by Product 5 Companion Animal Diagnostics Market, by Animal Type 6 Companion Animal Diagnostics Market, by Geography 7 Leading Companies For more information visit http://www.researchandmarkets.com/research/qj..._companion.
ZTS: 46.19 (-1.20), ABAX: 45.54 (+0.01), MRK: 56.11 (-0.70), NEOG: 52.39 (-0.20), IDXX: 88.92 (+0.04), WOOF: 63.84 (-1.00), MR: 27.94 (+0.07)
Mindray Announced Shareholder Resolutions Post 2015 Annual General Meeting
PR Newswire - Tue Dec 29, 4:00PM CST
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 28, 2015.
MR: 27.94 (+0.07)
Anemia / Vitamin Tests Pipeline Review, 2015 - Analysis, Technologies & Forecasts
M2 - Tue Dec 29, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/93z393/anemia_vitamin) has announced the addition of the "Anemia / Vitamin Tests - Pipeline Review, 2015" report to their offering. The Medical Devices sector report, Anemia / Vitamin Tests - Pipeline Review, 2015" provides an overview of Anemia / Vitamin Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. Key Topics Covered: - Extensive coverage of the Anemia / Vitamin Tests under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Anemia / Vitamin Tests and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage Benefits of this Report: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Anemia / Vitamin Tests under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Mentioned: - Alere Inc. - AMS Diagnostics, LLC. - Analyticon Biotechnologies AG - Beckman Coulter, Inc. - Carolina Liquid Chemistries Corp. - ELITech Group - Genesis Detection Systems, Inc. - Infigo Diagnostics Ltd - Mindray Medical International Limited - Randox Laboratories Limited - Roche Diagnostics International Ltd. - Siemens Healthcare Diagnostics Inc. - Tosoh Bioscience, Inc. - University of North Carolina - Vital Diagnostics, Inc. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Products under Development 4 Anemia / Vitamin Tests - Pipeline Products under Development by Companies 5 Anemia / Vitamin Tests Companies and Product Overview 6 Anemia / Vitamin Tests- Recent Developments 7 Appendix For more information visit http://www.researchandmarkets.com/research/93...ia_vitamin
ALR: 42.43 (-0.35), MR: 27.94 (+0.07)
Mindray Medical International Set to Possibly Pullback After Yesterday's Rally of 1.81%
Comtex SmarTrend(R) - Thu Dec 24, 6:03PM CST
Mindray Medical International (NYSE:MR) traded in a range yesterday that spanned from a low of $26.96 to a high of $27.58. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $27.04 on volume of 197,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MR: 27.94 (+0.07)
SmarTrend Watching for Potential Pullback in Shares of Mindray Medical International After 1.81% Gain
Comtex SmarTrend(R) - Thu Dec 24, 6:02PM CST
Mindray Medical International (NYSE:MR) traded in a range yesterday that spanned from a low of $26.96 to a high of $27.58. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $27.04 on volume of 197,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MR: 27.94 (+0.07)
Global Veterinary Diagnostics Market Report - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Tue Dec 15, 8:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/739pwl/global_veterinary) has announced the addition of the "Global Veterinary Diagnostics Market Analysis & Trends - Industry Forecast to 2020" report to their offering. This industry report analyzes the global markets for Veterinary Diagnostics across all the given segments in the research scope. It presents historical market data for 2012, 2013 and 2014, and forecasts till 2020. The report focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world. A special focus has been made on 17 countries such as U.S., Canada, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary research and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures. The Veterinary Diagnostics Market report includes 203 tables, charts and graphs for visual analysis. Report Highlights: - Market trends observed since past 5 years - Forecasted market size till 2020, using estimated market values as the base numbers - Key market trends across the business segments and various geographies - Key developments and strategies observed in the market - In-depth profiling of major players and upcoming prominent players - Market opportunities and recommendations for new investments Companies Mentioned : - ABAXIS, Inc. - HESKA Corporation - IDEXX Laboratories, Inc. - IDVET - Mindray Medical International Ltd. - Neogen Corporation - Thermo Fisher Scientific Inc. - VCA Antech, Inc. - Virbac SA - Zoetis, Inc. Report Structure: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Veterinary Diagnostics market by End User 5 Veterinary Diagnostics market by Product Type 6 Veterinary Diagnostics market by Animal Type 7 Veterinary Diagnostics market by Geography 8 Leading Companies For more information visit http://www.researchandmarkets.com/research/73...veterinary
ZTS: 46.19 (-1.20), ABAX: 45.54 (+0.01), NEOG: 52.39 (-0.20), IDXX: 88.92 (+0.04), WOOF: 63.84 (-1.00), MR: 27.94 (+0.07)
Cell Surface Markers Identification - Global Strategic Business Report 2015-2020 - Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth
M2 - Fri Dec 11, 6:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/ctnc8s/cell_surface) has announced the addition of the "Cell Surface Markers Identification - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets: Research, and Diagnosis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 79 companies including many key and niche players such as - Abbott Laboratories (US) - BD Biosciences (US) - Beckman Coulter, Inc. (US) - Bio-Rad Laboratories, Inc. (US) - CellaVision AB (Sweden) - Dako Denmark A/S (Denmark) - eBioscience, Inc. (US) - EMD Millipore (US) - F. Hoffmann-La Roche Ltd. (Switzerland) - Grifols, S.A (Spain) - Horiba Ltd. (Japan) - Mindray Medical International Limited (China) - Ortho-Clinical Diagnostics, Inc. (US) - QIAGEN N.V. (The Netherlands) - Siemens Healthcare (Germany) - Sysmex Corporation (Japan) - Thermo Fisher Scientific, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. NOTEWORTHY MARKET TRENDS & GROWTH DRIVERS 3. COMPETITION 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/LAUNCHES 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 79 (including Divisions/Subsidiaries - 105) - The United States (47) - Canada (1) - Japan (
- Europe (30) - - France (4) - - Germany ( - - The United Kingdom (5) - - Italy (1) - - Spain (2) - - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (18) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/ct...ll_surface
ABT: 37.86 (-0.54), QGEN: 21.43 (-0.28), MR: 27.94 (+0.07)
Global Veterinary Imaging Market Worth USD 2.8 Billion by 2020 - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Thu Dec 10, 9:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/qzvlqk/veterinary) has announced the addition of the "Veterinary Imaging Market by Product & by Application - Global Forecast to 2020" report to their offering. The global veterinary imaging market is expected to grow at a CAGR of 6.6% during the forecast period of 2015 to 2020, reaching USD 2.8 Billion by 2020 Benefits of this Report: - The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares. Key Topics Covered: - Market Penetration: Comprehensive information on product portfolios offered by top players in the veterinary imaging market. The report analyzes the veterinary imaging market by product, therapeutic areas, type of animal, and end user across all regions. - Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the veterinary imaging market. - Market Development: Comprehensive information on the lucrative emerging markets by product, therapeutic area, type of animal, end user, and region. - Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the veterinary imaging market. - Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analysis of leading players in the veterinary imaging market. Companies Mentioned: - Agfa-Gevaert N.V. - Carestream Health, Inc. - Diagnostic Imaging Systems, Inc. - Esaote Spa - Ge Healthcare (A Division of General Electric Company) - Hallmarq Veterinary Imaging Ltd. - Idexx Laboratories, Inc. - Mindray Medical International Ltd. - Minxray Inc. - Toshiba Corporation - Vca Antech, Inc. Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Veterinary Imaging Market, By Product 8 Global Veterinary Imaging Market, By Animal Type 9 Global Veterinary Imaging Market, By Therapeutic Area 10 Global Veterinary Imaging Market, By End User 11 Global Veterinary Imaging Market, By Region 12 Competitive Landscape 13 Company Profiles 14 Appendix For more information visit http://www.researchandmarkets.com/research/qzvlqk/veterinary
GE: 29.83 (-0.21), MR: 27.94 (+0.07)
China Clinical Chemistry Market Outlook to 2021 - Corporate-Level Profiles of Key Companies
M2 - Wed Dec 09, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/p8nh2p/china_clinical) has announced the addition of the "China Clinical Chemistry Market Outlook to 2021" report to their offering. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the China Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, China 4 Overview of Key Companies in China, Clinical Chemistry Market 5 Clinical Chemistry Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned - F. Hoffmann-La Roche Ltd. - Siemens Healthcare - Danaher Corporation - Bio-Rad Laboratories, Inc. - Mindray Medical International Limited - Abbott Laboratories - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/p8...a_clinical
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
China Haematology Market Outlook to 2021 - Analysis, Trends, Technologies & Forecast Report
M2 - Tue Dec 08, 4:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/mn3h2f/china_haematology) has announced the addition of the "China Haematology Market Outlook to 2021" report to their offering. Our new report, "China Haematology Market Outlook to 2021", provides key market data on the China Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: - Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the China Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Sysmex Corporation - Siemens Healthcare - Mindray Medical International Limited - Nihon Kohden Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - bioMerieux S.A. - Abbott Laboratories Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Haematology Market, China 4 Overview of Key Companies in China, Haematology Market 5 Haematology Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix For more information visit http://www.researchandmarkets.com/research/mn...aematology
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
Mindray Announces Completion of Going Private Transaction
PR Newswire - Thu Mar 03, 3:01PM CST
Mindray Medical International Limited ("Mindray" or the "Company", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the completion of its merger (the "merger"
with Solid Union Limited ("Merger Sub" , a wholly-owned subsidiary of Excelsior Union Limited ("Parent" , pursuant to the previously announced agreement and plan of merger (the "Merger Agreement" dated as of November 4, 2015 and amended on December 20, 2015, among the Company, Parent and Merger Sub. As a result of the merger, the Company has ceased to be a publicly traded company and became a wholly owned subsidiary of Parent. MR: 27.94 (+0.07)
11.7% Return Seen to Date on SmarTrend Mindray Medical International Call (MR)
Comtex SmarTrend(R) - Wed Mar 02, 12:02PM CST
SmarTrend identified an Uptrend for Mindray Medical International (NYSE:MR) on November 3rd, 2015 at $24.91. In approximately 4 months, Mindray Medical International has returned 11.70% as of today's recent price of $27.83.
MR: 27.94 (+0.07)
Profitable Ideas in Untold Names -- TransEnterix, Endologix, Mindray Medical Intl., and Hill-Rom Holdings
ACCESSWIRE - Tue Feb 09, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / February 09, 2016 / At ValuableInvestment.com we are aware that volume and moving average numbers impress. So, these are the top trades, TransEnterix Inc. (NYSE MKT: TRXC), Endologix Inc. (NASDAQ: ELGX), Mindray Medical International Ltd (NYSE:MR), and Hill-Rom Holdings Inc. (NYSE: HRC), for making money when big names are down. Find out which stocks could produce triple digit returns this month by clicking here:
TRXC: 1.45 (unch), MR: 27.94 (+0.07), ELGX: 12.88 (+0.20), HRC: 49.35 (-0.75)
BRIC Haematology Market Outlook to 2021
M2 - Tue Jan 19, 10:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lfvn3k/bric_haematology) has announced the addition of the "BRIC Haematology Market Outlook to 2021" report to their offering. "BRIC Haematology Market Outlook to 2021", provides key market data on the BRIC Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the BRIC Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Haematology Market, BRIC 4 Haematology Market, Brazil 5 Haematology Market, Russia 6 Haematology Market, India 7 Haematology Market, China 8 Overview of Key Companies in BRIC Haematology Market 9 Haematology Market Pipeline Products 10 Appendix Companies featured - Siemens Healthcare - Sysmex Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Horiba, Ltd. - Transasia Bio-Medicals Ltd. - Mindray Medical International Limited - Trivitron Healthcare Pvt Ltd. - Bio-Rad Laboratories, Inc. - bioMerieux S.A. For more information visit http://www.researchandmarkets.com/research/lf...aematology
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
Global Ultrasound Market Report 2016-2021 - Market is Dominated by GE, Siemens & Philips
M2 - Tue Jan 19, 9:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/dzgr8z/global_ultrasound) has announced the addition of the "Global Ultrasound Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global ultrasound market is expected to grow at a CAGR of 5% for the forecasted period of 2015-2021 The market is dominated by some of the major healthcare companies which includes GE healthcare, Siemens healthcare and Philips healthcare. Market growth is driven by various factors which includes increase in the number of cancer patients which is creating huge demand for ultrasound system market. Rise in the prevalence of CVD and other life style oriented diseases is also driving the ultrasound system market. Ultrasound is widely used to monitor the growth of baby during pregnancy, hence a constant rise in birth rates and awareness amongst the masses creates huge scope for ultrasound system market. Innovations such as advent of 3D and 4D imaging is creating opportunities for the market player. However, the market is restrained by few factors such as reimbursement policies in emerging nations. The high price and unavailability of reimbursements keeps a large group of patients from using ultrasound services. Market is segmented on the basis of technology, applications and products. Ultrasound system market by technology includes diagnostics ultrasound market and therapeutic ultrasound market. The ultrasound system market which is also segmented on the basis of product includes segmentation on the basis of displays, on the basis of portability. Ultrasound system market is also segmented on the basis of applications which include radiology imaging applications gynaecological, cardio logical, and urological and others. Europe accounted for highest market share driven by an aging population and high awareness related to life threatening diseases. North America has the second highest market share followed by Asia Pacific and Rest of the world. Asia Pacific market has the highest market growth. Asia Pacific market is expected to grow at a CAGR of 6%. The market includes major companies such as Analogic Corporation, Esaote S.P.A, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Mindray Medical International Ltd., and Philips Healthcare, Samsung, Medison Co. Ltd., Siemens Healthcare and other. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Analogic Corporation - Esaote S.P.A - Fujifilm Holdings Corporation - GE Healthcare - Hitachi Medical Corporation - Mindray Medical International Ltd. - Philips Healthcare - Samsung Medison Co. Ltd. - Siemens Healthcare - Medtronic Inc - Toshiba Medical Systems Corporation - Roche Diagnostics Ltd. - Philips corporation - Stryker corporation - Smith and nephew inc - Johnson & Johnson - Sony - Zimmer holdings - St. Jude medical Inc - Thermo fisher scientific - Abiant Inc - EKF diagnostics holdings inc - Myriad RBM inc - Oligomerix inc - Opko health inc - Osta biotechnologies inc - Psynova neurotech ltd - Ridge diagnostics - Satori pharmaceutical inc For more information visit http://www.researchandmarkets.com/research/dz...ultrasound
JNJ: 116.79 (-0.22), MDT: 85.70 (unch), ALOG: 83.75 (-0.50), MR: 27.94 (+0.07), SYK: 114.44 (-0.12)
Global MRI Systems Market Report 2015-2021 - Global increase in neurological diseases is expected to drive MRI systems market
M2 - Tue Jan 19, 8:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/wcsjfb/global_mri) has announced the addition of the "Global MRI Systems Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global MRI systems market is expected to grow at a CAGR of 5.2% for the forecasted period of 2015 to 2021 MRI systems market is driven by various factors which include global increase in neurological diseases, global rise in cancer, CVD and other life style oriented diseases, global rise in adoption of diagnostics system. Research and development, innovation and technological advancement enables the global MRI systems market to grow fast. Global rise in healthcare expenditure is also favourable for global MRI systems market. However, the market is restrained by reimbursement policies in various regions especially emerging markets such as India and China. There is a very high cost involved in setting up MRI systems in hospitals and clinics. The hospitals and clinics have to make infrastructural changes to accommodate a new MRI machine. Some MRI machines may cost over $800,000 to $1 million. Market also faces challenges such as creating awareness in emerging economies and stringent government policies and regulations. Market segmentation is on the basis of application which includes brain and neurological MRI market, spine and musculoskeletal MRI market, vascular MRI market, pelvic and abdominal MRI market, breast MRI market and cardiac MRI market. MRI market is also segmented on the basis of architecture which includes closed MRI systems market and open MRI systems market. Field strength is also taken as a basis of segmentation. The sub segments include low to mid field MRI systems, high field MRI systems, very high field MRI systems and ultra-high field MRI systems. North American market has the highest market share amongst geographies. It is followed by Asia Pacific, Europe and Rest of the world. Asia Pacific market is expected to record highest CAGR amongst all regions. Market consists of major players such as Aurora imaging technology Inc, Esoate SPA, Fona corporation, IMRIS, Inc, Neusoft medical systems co. ltd, Philips healthcare, Esaote S.P.A, GE Healthcare, Hitachi Medical Corporation and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographic analysis 8. Company Profiles - Aurora imaging technology Inc - Esoate SPA - Fona corporation - IMRIS, Inc - Neusoft medical systems s co. ltd - Philips healthcare - Esaote S.P.A - GE Healthcare - Hitachi Medical Corporation - Mindray Medical International Ltd. - Samsung Medison Co. Ltd. - Siemens Healthcare - Medtronic Inc - Toshiba Medical Systems s Corporation - Roche Diagnostics Ltd. - Philips corporation - Stryker corporation - Smith and nephew Inc - Johnson & Johnson - Sony - Zimmer holdings - St. Jude medical Inc - Thermo fisher scientific - Abiant Inc - EKF diagnostics holdings Inc - Myriad RBM Inc - Oligomerix Inc - Opko health Inc - Osta biotechnologies Inc - Psynova neurotech ltd - Ridge diagnostics For more information visit http://www.researchandmarkets.com/research/wcsjfb/global_mri
JNJ: 116.79 (-0.22), MDT: 85.70 (unch), MR: 27.94 (+0.07), SYK: 114.44 (-0.12)
Mindray Announces Extraordinary General Meeting of Shareholders
PR Newswire - Tue Jan 19, 7:11AM CST
Mindray Medical International Limited ("Mindray" or the "Company", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has called an extraordinary general meeting of shareholders (the "EGM"
, to be held on February 26, 2016 at 11:00 a.m. (Hong Kong time), at the Company's Hong Kong office at FLAT/RM 15-16 BLK 1 11/F, Grand Century, 193 Prince Edward West Road, Mongkok KL, Hong Kong. The meeting is being held to consider and vote on, among other matters, the proposal to authorize and approve the previously announced agreement and plan of merger (the "Merger Agreement" dated as of November 4, 2015 as amended on December 20, 2015, among the Company, Excelsior Union Limited ("Parent" and Solid Union Limited, a wholly owned subsidiary of Parent ("Merger Sub" , the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, substantially in the form attached as Annex A to the Merger Agreement (the "Plan of Merger" , and the transactions contemplated thereby, including the Merger (as defined below). MR: 27.94 (+0.07)
EU5 Clinical Chemistry Market Outlook to 2021
M2 - Fri Jan 15, 7:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/ns6xbw/eu5_clinical) has announced the addition of the "EU5 Clinical Chemistry Market Outlook to 2021" report to their offering. "EU5 Clinical Chemistry Market Outlook to 2021", provides key market data on the EU5 Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the EU5 Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, EU5 4 Clinical Chemistry Market, France 5 Clinical Chemistry Market, Germany 6 Clinical Chemistry Market, Italy 7 Clinical Chemistry Market, Spain 8 Clinical Chemistry Market, United Kingdom 9 Overview of Key Companies in EU5 Clinical Chemistry Market 10 Clinical Chemistry Market Pipeline Products 11 Recent Developments 12 Appendix Companies Mentioned - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Danaher Corporation - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation - ELITech Group - Mindray Medical International Limited For more information visit http://www.researchandmarkets.com/research/ns...5_clinical
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
Global Companion Animal Diagnostics Market Worth USD 1.55 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: ABAXIS, Elanco & Neogen Corporation
M2 - Thu Jan 14, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/qjqfhw/global_companion) has announced the addition of the "Global Companion Animal Diagnostics Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Companion Animal Diagnostics Market is poised to grow at a CAGR of around 8.9% in the next 5 years to reach approximately $1.55 billion by 2020. This industry report analyzes the global markets for Companion Animal Diagnostics across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The market data is gathered from extensive primary research and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures. The Companion Animal Diagnostics Market report provides 161 data tables, includes charts and graphs for visual analysis. Key Topics Covered: - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Companies Mentioned: - ABAXIS, Inc. - Boehringer Ingelheim - Elanco - HESKA Corporation - IDEXX Laboratories, Inc. - IDVET - Merck - Mindray Medical International Ltd. - Neogen Corporation - Thermo Fisher Scientific Inc - VCA Antech, Inc. - Virbac SA - Zoetis, Inc. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Companion Animal Diagnostics Market, by Product 5 Companion Animal Diagnostics Market, by Animal Type 6 Companion Animal Diagnostics Market, by Geography 7 Leading Companies For more information visit http://www.researchandmarkets.com/research/qj..._companion.
ZTS: 46.19 (-1.20), ABAX: 45.54 (+0.01), MRK: 56.11 (-0.70), NEOG: 52.39 (-0.20), IDXX: 88.92 (+0.04), WOOF: 63.84 (-1.00), MR: 27.94 (+0.07)
Mindray Announced Shareholder Resolutions Post 2015 Annual General Meeting
PR Newswire - Tue Dec 29, 4:00PM CST
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 28, 2015.
MR: 27.94 (+0.07)
Anemia / Vitamin Tests Pipeline Review, 2015 - Analysis, Technologies & Forecasts
M2 - Tue Dec 29, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/93z393/anemia_vitamin) has announced the addition of the "Anemia / Vitamin Tests - Pipeline Review, 2015" report to their offering. The Medical Devices sector report, Anemia / Vitamin Tests - Pipeline Review, 2015" provides an overview of Anemia / Vitamin Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. Key Topics Covered: - Extensive coverage of the Anemia / Vitamin Tests under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Anemia / Vitamin Tests and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage Benefits of this Report: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Anemia / Vitamin Tests under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Mentioned: - Alere Inc. - AMS Diagnostics, LLC. - Analyticon Biotechnologies AG - Beckman Coulter, Inc. - Carolina Liquid Chemistries Corp. - ELITech Group - Genesis Detection Systems, Inc. - Infigo Diagnostics Ltd - Mindray Medical International Limited - Randox Laboratories Limited - Roche Diagnostics International Ltd. - Siemens Healthcare Diagnostics Inc. - Tosoh Bioscience, Inc. - University of North Carolina - Vital Diagnostics, Inc. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Products under Development 4 Anemia / Vitamin Tests - Pipeline Products under Development by Companies 5 Anemia / Vitamin Tests Companies and Product Overview 6 Anemia / Vitamin Tests- Recent Developments 7 Appendix For more information visit http://www.researchandmarkets.com/research/93...ia_vitamin
ALR: 42.43 (-0.35), MR: 27.94 (+0.07)
Mindray Medical International Set to Possibly Pullback After Yesterday's Rally of 1.81%
Comtex SmarTrend(R) - Thu Dec 24, 6:03PM CST
Mindray Medical International (NYSE:MR) traded in a range yesterday that spanned from a low of $26.96 to a high of $27.58. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $27.04 on volume of 197,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MR: 27.94 (+0.07)
SmarTrend Watching for Potential Pullback in Shares of Mindray Medical International After 1.81% Gain
Comtex SmarTrend(R) - Thu Dec 24, 6:02PM CST
Mindray Medical International (NYSE:MR) traded in a range yesterday that spanned from a low of $26.96 to a high of $27.58. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $27.04 on volume of 197,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MR: 27.94 (+0.07)
Global Veterinary Diagnostics Market Report - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Tue Dec 15, 8:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/739pwl/global_veterinary) has announced the addition of the "Global Veterinary Diagnostics Market Analysis & Trends - Industry Forecast to 2020" report to their offering. This industry report analyzes the global markets for Veterinary Diagnostics across all the given segments in the research scope. It presents historical market data for 2012, 2013 and 2014, and forecasts till 2020. The report focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world. A special focus has been made on 17 countries such as U.S., Canada, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary research and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures. The Veterinary Diagnostics Market report includes 203 tables, charts and graphs for visual analysis. Report Highlights: - Market trends observed since past 5 years - Forecasted market size till 2020, using estimated market values as the base numbers - Key market trends across the business segments and various geographies - Key developments and strategies observed in the market - In-depth profiling of major players and upcoming prominent players - Market opportunities and recommendations for new investments Companies Mentioned : - ABAXIS, Inc. - HESKA Corporation - IDEXX Laboratories, Inc. - IDVET - Mindray Medical International Ltd. - Neogen Corporation - Thermo Fisher Scientific Inc. - VCA Antech, Inc. - Virbac SA - Zoetis, Inc. Report Structure: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Veterinary Diagnostics market by End User 5 Veterinary Diagnostics market by Product Type 6 Veterinary Diagnostics market by Animal Type 7 Veterinary Diagnostics market by Geography 8 Leading Companies For more information visit http://www.researchandmarkets.com/research/73...veterinary
ZTS: 46.19 (-1.20), ABAX: 45.54 (+0.01), NEOG: 52.39 (-0.20), IDXX: 88.92 (+0.04), WOOF: 63.84 (-1.00), MR: 27.94 (+0.07)
Cell Surface Markers Identification - Global Strategic Business Report 2015-2020 - Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth
M2 - Fri Dec 11, 6:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/ctnc8s/cell_surface) has announced the addition of the "Cell Surface Markers Identification - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets: Research, and Diagnosis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 79 companies including many key and niche players such as - Abbott Laboratories (US) - BD Biosciences (US) - Beckman Coulter, Inc. (US) - Bio-Rad Laboratories, Inc. (US) - CellaVision AB (Sweden) - Dako Denmark A/S (Denmark) - eBioscience, Inc. (US) - EMD Millipore (US) - F. Hoffmann-La Roche Ltd. (Switzerland) - Grifols, S.A (Spain) - Horiba Ltd. (Japan) - Mindray Medical International Limited (China) - Ortho-Clinical Diagnostics, Inc. (US) - QIAGEN N.V. (The Netherlands) - Siemens Healthcare (Germany) - Sysmex Corporation (Japan) - Thermo Fisher Scientific, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. NOTEWORTHY MARKET TRENDS & GROWTH DRIVERS 3. COMPETITION 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/LAUNCHES 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 79 (including Divisions/Subsidiaries - 105) - The United States (47) - Canada (1) - Japan (
- Europe (30) - - France (4) - - Germany ( - - The United Kingdom (5) - - Italy (1) - - Spain (2) - - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (18) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/ct...ll_surface ABT: 37.86 (-0.54), QGEN: 21.43 (-0.28), MR: 27.94 (+0.07)
Global Veterinary Imaging Market Worth USD 2.8 Billion by 2020 - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Thu Dec 10, 9:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/qzvlqk/veterinary) has announced the addition of the "Veterinary Imaging Market by Product & by Application - Global Forecast to 2020" report to their offering. The global veterinary imaging market is expected to grow at a CAGR of 6.6% during the forecast period of 2015 to 2020, reaching USD 2.8 Billion by 2020 Benefits of this Report: - The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares. Key Topics Covered: - Market Penetration: Comprehensive information on product portfolios offered by top players in the veterinary imaging market. The report analyzes the veterinary imaging market by product, therapeutic areas, type of animal, and end user across all regions. - Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the veterinary imaging market. - Market Development: Comprehensive information on the lucrative emerging markets by product, therapeutic area, type of animal, end user, and region. - Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the veterinary imaging market. - Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analysis of leading players in the veterinary imaging market. Companies Mentioned: - Agfa-Gevaert N.V. - Carestream Health, Inc. - Diagnostic Imaging Systems, Inc. - Esaote Spa - Ge Healthcare (A Division of General Electric Company) - Hallmarq Veterinary Imaging Ltd. - Idexx Laboratories, Inc. - Mindray Medical International Ltd. - Minxray Inc. - Toshiba Corporation - Vca Antech, Inc. Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Veterinary Imaging Market, By Product 8 Global Veterinary Imaging Market, By Animal Type 9 Global Veterinary Imaging Market, By Therapeutic Area 10 Global Veterinary Imaging Market, By End User 11 Global Veterinary Imaging Market, By Region 12 Competitive Landscape 13 Company Profiles 14 Appendix For more information visit http://www.researchandmarkets.com/research/qzvlqk/veterinary
GE: 29.83 (-0.21), MR: 27.94 (+0.07)
China Clinical Chemistry Market Outlook to 2021 - Corporate-Level Profiles of Key Companies
M2 - Wed Dec 09, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/p8nh2p/china_clinical) has announced the addition of the "China Clinical Chemistry Market Outlook to 2021" report to their offering. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the China Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, China 4 Overview of Key Companies in China, Clinical Chemistry Market 5 Clinical Chemistry Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned - F. Hoffmann-La Roche Ltd. - Siemens Healthcare - Danaher Corporation - Bio-Rad Laboratories, Inc. - Mindray Medical International Limited - Abbott Laboratories - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/p8...a_clinical
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
China Haematology Market Outlook to 2021 - Analysis, Trends, Technologies & Forecast Report
M2 - Tue Dec 08, 4:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/mn3h2f/china_haematology) has announced the addition of the "China Haematology Market Outlook to 2021" report to their offering. Our new report, "China Haematology Market Outlook to 2021", provides key market data on the China Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: - Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the China Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Sysmex Corporation - Siemens Healthcare - Mindray Medical International Limited - Nihon Kohden Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - bioMerieux S.A. - Abbott Laboratories Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Haematology Market, China 4 Overview of Key Companies in China, Haematology Market 5 Haematology Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix For more information visit http://www.researchandmarkets.com/research/mn...aematology
ABT: 37.86 (-0.54), DHR: 98.09 (-1.22), MR: 27.94 (+0.07)
